亞太地區的自我監測血糖儀(SMBG)市場 - 成長，趨勢，預測(2019年∼2024年)
Asia-Pacific Self-monitoring Blood Glucose Devices Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||808268|
|出版日期||內容資訊||英文 95 Pages
|亞太地區的自我監測血糖儀(SMBG)市場 - 成長，趨勢，預測(2019年∼2024年) Asia-Pacific Self-monitoring Blood Glucose Devices Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年02月01日||內容資訊: 英文 95 Pages||
The Asia-Pacific self-monitoring blood glucose devices market is segmented into blood glucose meters, blood glucose testing strips, and lancets. Self-monitoring blood glucose (SMBG) devices markets across the Asia Pacific are still in their growing phases. Approximately 10% of the diabetes population, in the Asia Pacific region, are type-1 diabetic and 90% are type-2 diabetes patients. Type-1 patients need to take insulin throughout their life, along with maintaining a healthy diet and regular physical exercise. Type-2 patients need to eat healthily, be physically active, and take a regular test to check their blood glucose level. They may also need to take oral medication and insulin to control the glucose levels in the blood. Diabetes, as a condition, has many complications associated with it, including diabetic ketoacidosis and non-ketotic hyperosmolar coma. Serious long-term complications include heart disease, stroke, kidney failure, foot ulcers, and damage to the eyes. To avoid these complications, the patients need to regularly monitor their blood glucose levels to keep their glucose levels in control and hence, patients check their blood glucose levels with the help of glucometers and test strips.
The market is segmented by component (Glucometer device, Test Strips and Lancets), by end-user (hospital use and personal use) and by geography.
In Asia-Pacific, Glucometer Device Segment Registered the Highest CAGR with 7.23%
The Glucometer Devices market is expected to see high sales in the future, owing to the rising awareness and innovations associated with the glucometer. The technologies in glucometer devices are leading the glucometer devices market. Glucometer companies designing smart glucometer devices that are now connected to mobile devices help diabetes patients, their, parents, or friends know their health condition in critical times immediately. Even the companies with mobile apps like, Roche's Mysugar logbook app, and the companies that don't have their mobile app are trying to manufacture glucometers such that they go with all the diabetes mobile applications. The Arcadia Group designed smart glucometer devices that are connected to mobile devices created by Aggamatrix. For this, both the companies, Aggamatrix and Arcadia, got into an agreement.
China has the Highest Market Share in Asia-Pacific and Will Continue to Grow in the Future with the CAGR of 7.48%
In China, about 123 million patients were suffering from diabetes mellitus in 2019, with a prevalence rate of 11.2% among adults. Of the 123 million diabetic patients, 12.18 million were type-1 patients and 111.42 million were type-2 patients. These numbers are expected to increase during the forecast period. China holds the highest market share in the Asia-Pacific glucometer devices market. In China, due to the lifestyle and food habits, blood glucose fluctuations among insulin users are frequent from time to time. China is a mature market with the associated challenges of slow economic growth and ageing population. In 2019, in the Chinese blood glucose monitoring devices market, the consumables accounted for 87.5%, of which, 85.68% of the market share was held by test strips and the 14.3% was occupied by lancets.
The Asia-Pacific self-monitoring blood glucose devices market is highly fragmented with few major manufacturers gaining presence in major countries of the Asia-Pacific market, while the remaining market comprises other local or region-specific manufacturers. Mergers and acquisitions that happened between players in the recent past helped the companies to strengthen their market presence; for instance, In South Korea, Arkray started the Development Center in Gunpo, in 2018 to develop new systems for Arkray's main business of manufacturing self-monitoring blood glucose meters, test strips, and lancets.